Cargando…

Bias, Precision and Timeliness of Historical (Background) Rate Comparison Methods for Vaccine Safety Monitoring: An Empirical Multi-Database Analysis

Using real-world data and past vaccination data, we conducted a large-scale experiment to quantify bias, precision and timeliness of different study designs to estimate historical background (expected) compared to post-vaccination (observed) rates of safety events for several vaccines. We used negat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xintong, Lai, Lana YH, Ostropolets, Anna, Arshad, Faaizah, Tan, Eng Hooi, Casajust, Paula, Alshammari, Thamir M., Duarte-Salles, Talita, Minty, Evan P., Areia, Carlos, Pratt, Nicole, Ryan, Patrick B., Hripcsak, George, Suchard, Marc A., Schuemie, Martijn J., Prieto-Alhambra, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652333/ https://www.ncbi.nlm.nih.gov/pubmed/34899334 http://dx.doi.org/10.3389/fphar.2021.773875

Ejemplares similares

Current Approaches to Vaccine Safety Using Observational Data: A Rationale for the EUMAEUS (Evaluating Use of Methods for Adverse Events Under Surveillance-for Vaccines) Study Design
por: Lai, Lana YH, et al.
Publicado: (2022)

Vaccine Safety Surveillance Using Routinely Collected Healthcare Data—An Empirical Evaluation of Epidemiological Designs
por: Schuemie, Martijn J., et al.
Publicado: (2022)

Corrigendum: Vaccine safety surveillance using routinely collected healthcare data—An empirical evaluation of epidemiological designs
por: Schuemie, Martijn J., et al.
Publicado: (2022)

Serially Combining Epidemiological Designs Does Not Improve Overall Signal Detection in Vaccine Safety Surveillance
por: Arshad, Faaizah, et al.
Publicado: (2023)

Factors Influencing Background Incidence Rate Calculation: Systematic Empirical Evaluation Across an International Network of Observational Databases
por: Ostropolets, Anna, et al.
Publicado: (2022)

Characterising the background incidence rates of adverse events of special interest for covid-19 vaccines in eight countries: multinational network cohort study
por: Li, Xintong, et al.
Publicado: (2021)

Characterizing the incidence of adverse events of special interest for COVID-19 vaccines across eight countries: a multinational network cohort study
por: Li, Xintong, et al.
Publicado: (2021)

Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysis
por: Tan, Eng Hooi, et al.
Publicado: (2020)

Characterizing Anchoring Bias in Vaccine Comparator Selection Due to Health Care Utilization With COVID-19 and Influenza: Observational Cohort Study
por: Ostropolets, Anna, et al.
Publicado: (2022)

COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countries
por: Tan, Eng Hooi, et al.
Publicado: (2021)

Large-scale evidence generation and evaluation across a network of databases for type 2 diabetes mellitus (LEGEND-T2DM): a protocol for a series of multinational, real-world comparative cardiovascular effectiveness and safety studies
por: Khera, Rohan, et al.
Publicado: (2022)

Evaluating the impact of alternative phenotype definitions on incidence rates across a global data network
por: Makadia, Rupa, et al.
Publicado: (2023)

Characteristics and outcomes of COVID-19 patients with COPD from the United States, South Korea, and Europe
por: Moreno-Martos, David, et al.
Publicado: (2023)

Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and Spain
por: Roel, Elena, et al.
Publicado: (2021)

Baseline characteristics, management, and outcomes of 55,270 children and adolescents diagnosed with COVID-19 and 1,952,693 with influenza in France, Germany, Spain, South Korea and the United States: an international network cohort study
por: Duarte-Salles, Talita, et al.
Publicado: (2020)

Robust empirical calibration of p‐values using observational data
por: Schuemie, Martijn J., et al.
Publicado: (2016)

Improving reproducibility by using high-throughput observational studies with empirical calibration
por: Schuemie, Martijn J., et al.
Publicado: (2018)

Drawing Reproducible Conclusions from Observational Clinical Data with OHDSI
por: Hripcsak, George, et al.
Publicado: (2021)

COVID-19 vaccination effectiveness rates by week and sources of bias
por: Ostropolets, Anna, et al.
Publicado: (2021)

COVID-19 vaccination effectiveness rates by week and sources of bias: a retrospective cohort study
por: Ostropolets, Anna, et al.
Publicado: (2022)

Renin-angiotensin system blockers and susceptibility to COVID-19: a multinational open science cohort study
por: Morales, Daniel R., et al.
Publicado: (2020)

Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis
por: Morales, Daniel R, et al.
Publicado: (2020)

Phenotype Algorithms for the Identification and Characterization of Vaccine-Induced Thrombotic Thrombocytopenia in Real World Data: A Multinational Network Cohort Study
por: Shoaibi, Azza, et al.
Publicado: (2022)

Use of dialysis, tracheostomy, and extracorporeal membrane oxygenation among 842,928 patients hospitalized with COVID-19 in the United States
por: Burn, Edward, et al.
Publicado: (2021)

Principles of Large-scale Evidence Generation and Evaluation across a Network of Databases (LEGEND)
por: Schuemie, Martijn J, et al.
Publicado: (2020)

Large-scale evidence generation and evaluation across a network of databases (LEGEND): assessing validity using hypertension as a case study
por: Schuemie, Martijn J, et al.
Publicado: (2020)

Erratum to: Large-Scale Evidence Generation and Evaluation across a Network of Databases (LEGEND): Assessing Validity Using Hypertension as a Case Study
por: Schuemie, Martijn J, et al.
Publicado: (2020)

Heterologous vaccine regimens against COVID-19
por: Duarte-Salles, Talita, et al.
Publicado: (2021)

Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including >3.32 million people tested with real-time PCR and >219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United States
por: Golozar, Asieh, et al.
Publicado: (2020)

Comparison of Cardiovascular and Safety Outcomes of Chlorthalidone vs Hydrochlorothiazide to Treat Hypertension
por: Hripcsak, George, et al.
Publicado: (2020)

Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort study
por: Lane, Jennifer C E, et al.
Publicado: (2020)

Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study
por: Prats-Uribe, Albert, et al.
Publicado: (2021)

A plea to stop using the case‐control design in retrospective database studies
por: Schuemie, Martijn J., et al.
Publicado: (2019)

Multinational patterns of second line antihyperglycaemic drug initiation across cardiovascular risk groups: federated pharmacoepidemiological evaluation in LEGEND-T2DM
por: Khera, Rohan, et al.
Publicado: (2023)

Characterizing physicians’ information needs related to a gap in knowledge unmet by current evidence
por: Ostropolets, Anna, et al.
Publicado: (2020)

Implementation of the COVID-19 Vulnerability Index Across an International Network of Health Care Data Sets: Collaborative External Validation Study
por: Reps, Jenna M, et al.
Publicado: (2021)

Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study
por: Voss, Erica A., et al.
Publicado: (2023)

Alpha-1 blockers and susceptibility to COVID-19 in benign prostate hyperplasia patients : an international cohort study
por: Nishimura, Akihiko, et al.
Publicado: (2021)

International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patients
por: Nishimura, Akihiko, et al.
Publicado: (2022)

Characteristics and outcomes of patients with COVID-19 with and without prevalent hypertension: a multinational cohort study
por: Reyes, Carlen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_haisdj4gpfb6jn1v05vtq9s3ue